Insights filtered by:

Corporates

For large organisations, managing an extensive, expanding portfolio can be a significant intellectual property challenge. We work with multinational corporations in both the UK and overseas to support their in-house teams with IP prosecution, oppositions, and disputes, while helping them to develop cost-effective IP strategies for protecting and commercialising future innovation.

Clear all Corporates
Articles

Are digital twins as patentable as their physical counterparts?

We live in an increasingly digital world – not only do more of us communicate with each other and access information or content using ‘apps’ and the internet, but some of the work we may have previously conducted in the ‘real’ or physical world is now being performed using computer simulations or digital twins.

Read more
Articles

CRISPR: An update

What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA sequences found in bacteria.

Read more
Articles

What’s the scoop on the Mr Whippy decision?

Despite “convincing arguments” against the strength of the evidence of use submitted by Unilever Plc, following the close-cut decision of the IPO on the 11 November 2019, the applicants’

Read more
Podcast

The Greenshoots Podcast by Appleyard Lees – episode five – features of EPO virtual opposition hearings

Partners and patent attorneys Julia Gwilt and Bobby Smithson discuss: Features of EPO virtual opposition hearings | Unexpected pros | Discreet communication between attorney, client and witness | Learnings & tips | ‘Reading the room’ | Procedural quirks | Would the outcome have been different if parties attended in person?

Read more
Articles

Sufficiency at the UK Supreme Court in Regeneron Pharmaceuticals Inc v Kymab Ltd

The UK Supreme Court handed down the judgment in a much anticipated biotech decision on 24 June. The Court found that Regeneron’s patents are invalid for lack of sufficient disclosure.

Read more
Articles

Akebia and Fibrogen – Lord Justice Arnold applies “Doctrine of Equivalents”

In this judgment at the High Court, Lord Justice Arnold stepped down from the Court of Appeal to the High Court to hear the case. His findings on infringement may

Read more
Articles

Progressing innovation outside the lab: part three, physics and engineering innovation

Lab-based scientists may not be able to access their workspace during lockdown, but there are things that can be done remotely to further an IP programme. In part three of our series, “Progressing innovation outside the lab”, we outline strategic tasks that physics and engineering-focused researchers and scientists can complete to further intellectual property during time away from the lab.  

Read more
Articles

Pressing pause on intellectual property: Part three – trade marks

This three-part series examines how intellectual property protection can continue in a productive and effective way, during this time of remote working, shifting priorities, uncertainty and change.

Read more
Articles

The Trade Secrets Directive – Shh, Don’t Tell Anyone!

Bill Lister discusses 'trade secrets' and their benefits.

Read more
Articles

The IPEC: Quick and cost effective UK IP Litigation

The IPEC provides quick access to cost-effective justice for IP rights holders.

Read more
Articles

EPO to take a second look at double patenting

The European Patent Convention does not explicitly prohibit double patenting. However, the European Patent Office has, for some time now, prohibited the granting of two patents to the same applicant for the same subject matter.

Read more
1 2 8 9 10 11
Skip to content